IBDEI0L6 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,847,0)
 ;;=MYELOID NEOPLASMS & DISORDERS^13^93
 ;;^UTILITY(U,$J,358.4,848,0)
 ;;=LYMPHOID NEOPLASMS^10^93
 ;;^UTILITY(U,$J,358.4,849,0)
 ;;=GI CANCER^7^93
 ;;^UTILITY(U,$J,358.4,850,0)
 ;;=HEAD, NECK & LUNG NEOPLASMS^8^93
 ;;^UTILITY(U,$J,358.4,851,0)
 ;;=MISC. NEOPLASMS^12^93
 ;;^UTILITY(U,$J,358.4,852,0)
 ;;=METASTATIC SITES^11^93
 ;;^UTILITY(U,$J,358.4,853,0)
 ;;=COUNSELING & SCREENING^5^93
 ;;^UTILITY(U,$J,358.4,854,0)
 ;;=HEMOGLOBINOPATHIES^9^93
 ;;^UTILITY(U,$J,358.4,855,0)
 ;;=GENITOURINARY NEOPLASMS^6^93
 ;;^UTILITY(U,$J,358.4,856,0)
 ;;=BREAST & GYN NEOPLASMS^3^93
 ;;^UTILITY(U,$J,358.4,857,0)
 ;;=ARTIFICIAL OPENING STATUS^2^93
 ;;^UTILITY(U,$J,358.4,858,0)
 ;;=PERSONAL HX OF CANCER^14^93
 ;;^UTILITY(U,$J,358.4,859,0)
 ;;=SPECIAL SERVICES^5^94
 ;;^UTILITY(U,$J,358.4,860,0)
 ;;=TREATMENT^4^94
 ;;^UTILITY(U,$J,358.4,861,0)
 ;;=MISCELLANEOUS^7^94
 ;;^UTILITY(U,$J,358.4,862,0)
 ;;=IMMUNIZATIONS^6^94
 ;;^UTILITY(U,$J,358.4,863,0)
 ;;=CHEMO ADMINISTRATION^1^94
 ;;^UTILITY(U,$J,358.4,864,0)
 ;;=CHEMO DRUGS^2^94
 ;;^UTILITY(U,$J,358.4,865,0)
 ;;=OTHER DRUGS^3^94
 ;;^UTILITY(U,$J,358.4,866,0)
 ;;=NEW PATIENT^2^95
 ;;^UTILITY(U,$J,358.4,867,0)
 ;;=ESTABLISHED PATIENT^1^95
 ;;^UTILITY(U,$J,358.4,868,0)
 ;;=CONSULTATIONS^3^95
 ;;^UTILITY(U,$J,358.4,869,0)
 ;;=POST OP^4^95
 ;;^UTILITY(U,$J,358.4,870,0)
 ;;=ESOPHAGUS^2^96
 ;;^UTILITY(U,$J,358.4,871,0)
 ;;=STOMACH/DUODENUM^8^96
 ;;^UTILITY(U,$J,358.4,872,0)
 ;;=SMALL BOWEL^7^96
 ;;^UTILITY(U,$J,358.4,873,0)
 ;;=LARGE BOWEL/RECTUM^4^96
 ;;^UTILITY(U,$J,358.4,874,0)
 ;;=SYMPTOMS^1^96
 ;;^UTILITY(U,$J,358.4,875,0)
 ;;=LIVER^5^96
 ;;^UTILITY(U,$J,358.4,876,0)
 ;;=PANCREAS^6^96
 ;;^UTILITY(U,$J,358.4,877,0)
 ;;=GALLBLADDER^3^96
 ;;^UTILITY(U,$J,358.4,878,0)
 ;;=ESOPHAGUS^3^97
 ;;^UTILITY(U,$J,358.4,879,0)
 ;;=SMALL INTESTINE ENDOSCOPY^8^97
 ;;^UTILITY(U,$J,358.4,880,0)
 ;;=SIGMOIDOSCOPY/PROCTOSIGMOIDOSCOPY^7^97
 ;;^UTILITY(U,$J,358.4,881,0)
 ;;=COLONOSCOPY^1^97
 ;;^UTILITY(U,$J,358.4,882,0)
 ;;=ERCP^2^97
 ;;^UTILITY(U,$J,358.4,883,0)
 ;;=G-TUBE^4^97
 ;;^UTILITY(U,$J,358.4,884,0)
 ;;=MISCELLANEOUS-PROCEDURES^6^97
 ;;^UTILITY(U,$J,358.4,885,0)
 ;;=IMMUNIZATIONS/INJECTIONS^5^97
 ;;^UTILITY(U,$J,358.4,886,0)
 ;;=NEW PATIENT^2^98
 ;;^UTILITY(U,$J,358.4,887,0)
 ;;=ESTABLISHED PATIENT^1^98
 ;;^UTILITY(U,$J,358.4,888,0)
 ;;=CONSULTATIONS^3^98
 ;;^UTILITY(U,$J,358.4,889,0)
 ;;=POST-OP FOLLOW-UP^4^98
 ;;^UTILITY(U,$J,358.4,890,0)
 ;;=NEW PATIENT^2^99
 ;;^UTILITY(U,$J,358.4,891,0)
 ;;=ESTABLISHED PATIENT^1^99
 ;;^UTILITY(U,$J,358.4,892,0)
 ;;=CONSULTATIONS^3^99
 ;;^UTILITY(U,$J,358.4,893,0)
 ;;=PROCEDURES^1^100
 ;;^UTILITY(U,$J,358.4,894,0)
 ;;=CARDIOVASCULAR^2^101
 ;;^UTILITY(U,$J,358.4,895,0)
 ;;=DERMATOLOGY^3^101
 ;;^UTILITY(U,$J,358.4,896,0)
 ;;=GENERAL^1^101
 ;;^UTILITY(U,$J,358.4,897,0)
 ;;=EENT^4^101
 ;;^UTILITY(U,$J,358.4,898,0)
 ;;=ENDOCRINOLOGY^5^101
 ;;^UTILITY(U,$J,358.4,899,0)
 ;;=GI^6^101
 ;;^UTILITY(U,$J,358.4,900,0)
 ;;=HEMATOLOGY^7^101
 ;;^UTILITY(U,$J,358.4,901,0)
 ;;=HIV STATUS & RELATED DX^8^101
 ;;^UTILITY(U,$J,358.4,902,0)
 ;;=NEPHRO/GU^9^101
 ;;^UTILITY(U,$J,358.4,903,0)
 ;;=NEUROLOGY^10^101
 ;;^UTILITY(U,$J,358.4,904,0)
 ;;=PAIN^11^101
 ;;^UTILITY(U,$J,358.4,905,0)
 ;;=PYSCHIATRY/SUBSTANCE ABUSE^12^101
 ;;^UTILITY(U,$J,358.4,906,0)
 ;;=RHEUMATOLOGY^13^101
 ;;^UTILITY(U,$J,358.4,907,0)
 ;;=RESPIRATORY^14^101
 ;;^UTILITY(U,$J,358.4,908,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCE^.5^101
 ;;^UTILITY(U,$J,358.4,909,0)
 ;;=INITIAL OBSERVATION^1^102
 ;;^UTILITY(U,$J,358.4,910,0)
 ;;=INPT BEDSIDE VISIT-INITIAL CARE^4^102
 ;;^UTILITY(U,$J,358.4,911,0)
 ;;=INPT-CONSULTATIONS^6^102
 ;;^UTILITY(U,$J,358.4,912,0)
 ;;=OBSERVATION DISCHARGE^3^102
 ;;^UTILITY(U,$J,358.4,913,0)
 ;;=INPT BEDSIDE VISITS-DAILY VISITS^5^102
 ;;^UTILITY(U,$J,358.4,914,0)
 ;;=ADMIT & DISCHARGE SAME DAY^7^102
 ;;^UTILITY(U,$J,358.4,915,0)
 ;;=DISCHARGE DAY CODES^8^102
 ;;^UTILITY(U,$J,358.4,916,0)
 ;;=OBSERVATION SUBSEQUENT VISIT^2^102
 ;;^UTILITY(U,$J,358.4,917,0)
 ;;=CARDIOVASCULAR^3^103
 ;;^UTILITY(U,$J,358.4,918,0)
 ;;=RESPIRATORY^13^103
 ;;^UTILITY(U,$J,358.4,919,0)
 ;;=MUSCULOSKELETAL^10^103
 ;;^UTILITY(U,$J,358.4,920,0)
 ;;=NEUROLOGIC^11^103
 ;;^UTILITY(U,$J,358.4,921,0)
 ;;=GASTROENTEROLOGY^5^103
 ;;^UTILITY(U,$J,358.4,922,0)
 ;;=GENITOURINARY^6^103
 ;;^UTILITY(U,$J,358.4,923,0)
 ;;=HEMATOLOGY/ONCOLOGY^7^103
 ;;^UTILITY(U,$J,358.4,924,0)
 ;;=INJURY/TRAUMA^8^103
 ;;^UTILITY(U,$J,358.4,925,0)
 ;;=SIGNS/SYMPTOMS^2^103
 ;;^UTILITY(U,$J,358.4,926,0)
 ;;=PAIN^12^103
 ;;^UTILITY(U,$J,358.4,927,0)
 ;;=COMPLICATIONS^4^103
 ;;^UTILITY(U,$J,358.4,928,0)
 ;;=MASS^9^103
 ;;^UTILITY(U,$J,358.4,929,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^103
 ;;^UTILITY(U,$J,358.4,930,0)
 ;;=RESPIRATORY^10^104
 ;;^UTILITY(U,$J,358.4,931,0)
 ;;=CARDIOVASCULAR^4^104
 ;;^UTILITY(U,$J,358.4,932,0)
 ;;=ABDOMINAL PAIN^2^104
 ;;^UTILITY(U,$J,358.4,933,0)
 ;;=AFTERCARE POST SURGERY^3^104
 ;;^UTILITY(U,$J,358.4,934,0)
 ;;=COMMON VASCULAR DX^1^104
 ;;^UTILITY(U,$J,358.4,935,0)
 ;;=POST-OP COMPLICATIONS^9^104
 ;;^UTILITY(U,$J,358.4,936,0)
 ;;=METASTATIC CANCER SITES^8^104
 ;;^UTILITY(U,$J,358.4,937,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^5^104
 ;;^UTILITY(U,$J,358.4,938,0)
 ;;=HEMATOLOGY/ONCOLOGY^6^104
 ;;^UTILITY(U,$J,358.4,939,0)
 ;;=INFECTIOUS DISEASE^7^104
 ;;^UTILITY(U,$J,358.4,940,0)
 ;;=BIOPSY^1^105
 ;;^UTILITY(U,$J,358.4,941,0)
 ;;=CENTRAL VENOUS ACCESS PROCEDURES^2^105
 ;;^UTILITY(U,$J,358.4,942,0)
 ;;=PERIPHERAL ANGIOPLASTIES^3^105
 ;;^UTILITY(U,$J,358.4,943,0)
 ;;=PROSTHETIC ANEURYSM REPAIR^4^105
 ;;^UTILITY(U,$J,358.4,944,0)
 ;;=VASCULAR INJECTION PROCEDURES^5^105
 ;;^UTILITY(U,$J,358.4,945,0)
 ;;=MFH-NON CLINICIAN VISIT CODES^2^106
 ;;^UTILITY(U,$J,358.4,946,0)
 ;;=NURSING PROCEDURES^3^106
 ;;^UTILITY(U,$J,358.4,947,0)
 ;;=SPLINTS^4^106
 ;;^UTILITY(U,$J,358.4,948,0)
 ;;=MFH-CLINICIAN VISIT CODES^1^106
 ;;^UTILITY(U,$J,358.4,949,0)
 ;;=VACCINE ADMINISTRATION^5^106
 ;;^UTILITY(U,$J,358.4,950,0)
 ;;=VACCINES^6^106
 ;;^UTILITY(U,$J,358.4,951,0)
 ;;=CIRCULATORY SYSTEM/CARDIOLOGY^2^107
 ;;^UTILITY(U,$J,358.4,952,0)
 ;;=ENDOCRINE/NUTR/METABOLIC/IMMUN DISORDERS^5^107
 ;;^UTILITY(U,$J,358.4,953,0)
 ;;=RESPIRATORY SYSTEM^15^107
 ;;^UTILITY(U,$J,358.4,954,0)
 ;;=MUSCULOSKELETAL SYSTEM^12^107
 ;;^UTILITY(U,$J,358.4,955,0)
 ;;=NERVOUS SYSTEM AND SENSE ORGANS^14^107
 ;;^UTILITY(U,$J,358.4,956,0)
 ;;=MENTAL,BEHAV,NEURODEVEL DISORDERS^11^107
 ;;^UTILITY(U,$J,358.4,957,0)
 ;;=DIGESTIVE^3^107
 ;;^UTILITY(U,$J,358.4,958,0)
 ;;=GU/URINARY^7^107
 ;;^UTILITY(U,$J,358.4,959,0)
 ;;=NEOPLASMS^13^107
 ;;^UTILITY(U,$J,358.4,960,0)
 ;;=INFECTIOUS AND PARASITIC DISEASES^9^107
 ;;^UTILITY(U,$J,358.4,961,0)
 ;;=SKIN/SUBCUTANEOUS TISSUE^17^107
 ;;^UTILITY(U,$J,358.4,962,0)
 ;;=HEALTH FACTORS (STATUS POST/HX OF)^8^107
 ;;^UTILITY(U,$J,358.4,963,0)
 ;;=INJURY AND POISONING^10^107
 ;;^UTILITY(U,$J,358.4,964,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^16^107
 ;;^UTILITY(U,$J,358.4,965,0)
 ;;=EXTERNAL CAUSES FOR INJURY^6^107
 ;;^UTILITY(U,$J,358.4,966,0)
 ;;=COMMON DIAGNOSES^1^107
 ;;^UTILITY(U,$J,358.4,967,0)
 ;;=DISEASES OF BLOOD/BLOOD FORMING ORGANS^4^107
 ;;^UTILITY(U,$J,358.4,968,0)
 ;;=NEW PATIENT^2^108
 ;;^UTILITY(U,$J,358.4,969,0)
 ;;=ESTABLISHED PATIENT^1^108
 ;;^UTILITY(U,$J,358.4,970,0)
 ;;=PREVENTIVE MED ESTAB^3^108
 ;;^UTILITY(U,$J,358.4,971,0)
 ;;=PREVENTIVE MED NEW^4^108
 ;;^UTILITY(U,$J,358.4,972,0)
 ;;=IMMUNIZATION^2^109
 ;;^UTILITY(U,$J,358.4,973,0)
 ;;=INJECTION^3^109
 ;;^UTILITY(U,$J,358.4,974,0)
 ;;=SKIN TEST^4^109
 ;;^UTILITY(U,$J,358.4,975,0)
 ;;=NURSING PROCEDURES^5^109
 ;;^UTILITY(U,$J,358.4,976,0)
 ;;=MINOR PROCEDURES^6^109
 ;;^UTILITY(U,$J,358.4,977,0)
 ;;=SPLINTS^9^109
 ;;^UTILITY(U,$J,358.4,978,0)
 ;;=REPAIR-SIMPLE SCALP,NK,TRUNK,GENTIALS^7^109
 ;;^UTILITY(U,$J,358.4,979,0)
 ;;=REPAIR-SIMPLE FACE,MUCOUS^8^109
 ;;^UTILITY(U,$J,358.4,980,0)
 ;;=CARDIOVASCULAR^1^110
 ;;^UTILITY(U,$J,358.4,981,0)
 ;;=ENDOCRINE/METABOLIC^5^110
 ;;^UTILITY(U,$J,358.4,982,0)
 ;;=PULMONARY^18^110
 ;;^UTILITY(U,$J,358.4,983,0)
 ;;=EENT^4^110
 ;;^UTILITY(U,$J,358.4,984,0)
 ;;=MUSCULOSKELETAL^13^110
 ;;^UTILITY(U,$J,358.4,985,0)
 ;;=NEURO^14^110
 ;;^UTILITY(U,$J,358.4,986,0)
 ;;=MENTAL HEALTH^12^110
 ;;^UTILITY(U,$J,358.4,987,0)
 ;;=GASTROENTEROLOGY^6^110
 ;;^UTILITY(U,$J,358.4,988,0)
 ;;=GU / RENAL^7^110
 ;;^UTILITY(U,$J,358.4,989,0)
 ;;=WOMEN'S HEALTH^21^110
 ;;^UTILITY(U,$J,358.4,990,0)
 ;;=HEMATOLOGY/ONCOLOGY^8^110
 ;;^UTILITY(U,$J,358.4,991,0)
 ;;=INFECTIOUS DISEASE^10^110
 ;;^UTILITY(U,$J,358.4,992,0)
 ;;=DERMATOLOGY^3^110
 ;;^UTILITY(U,$J,358.4,993,0)
 ;;=HISTORY OF ILLNESS^9^110
 ;;^UTILITY(U,$J,358.4,994,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^17^110
 ;;^UTILITY(U,$J,358.4,995,0)
 ;;=INJURY/TRAUMA^11^110
 ;;^UTILITY(U,$J,358.4,996,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^20^110
 ;;^UTILITY(U,$J,358.4,997,0)
 ;;=SEXUAL TRAUMA^19^110
 ;;^UTILITY(U,$J,358.4,998,0)
 ;;=PAIN^16^110
 ;;^UTILITY(U,$J,358.4,999,0)
 ;;=OTHER REASONS^15^110
 ;;^UTILITY(U,$J,358.4,1000,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^2^110
 ;;^UTILITY(U,$J,358.4,1001,0)
 ;;=PRESCRIBER CODES^2^111
 ;;^UTILITY(U,$J,358.4,1002,0)
 ;;=PSYCHOTHERAPY (INPT OR OUTPT)^3^111
 ;;^UTILITY(U,$J,358.4,1003,0)
 ;;=OTHER CODES^6^111
 ;;^UTILITY(U,$J,358.4,1004,0)
 ;;=BEHAVIOR ASSESSMENT/INTERVENTION^4^111
 ;;^UTILITY(U,$J,358.4,1005,0)
 ;;=TEAM CONFERENCE^9^111
 ;;^UTILITY(U,$J,358.4,1006,0)
 ;;=INTERACTIVE COMPLEXITY^5^111
 ;;^UTILITY(U,$J,358.4,1007,0)
 ;;=PSYCHIATRIC DIAGNOSTIC EVALUATION^1^111
 ;;^UTILITY(U,$J,358.4,1008,0)
 ;;=PSYCHOTHERAPY FOR CRISIS^7^111
 ;;^UTILITY(U,$J,358.4,1009,0)
 ;;=SUBSTANCE ABUSE^8^111
 ;;^UTILITY(U,$J,358.4,1010,0)
 ;;=ESTABLISHED PATIENT^1^112
 ;;^UTILITY(U,$J,358.4,1011,0)
 ;;=CONSULTATIONS^3^112
 ;;^UTILITY(U,$J,358.4,1012,0)
 ;;=NEW PATIENT^2^112
 ;;^UTILITY(U,$J,358.4,1013,0)
 ;;=INPATIENT CONSULTATIONS^4^112
 ;;^UTILITY(U,$J,358.4,1014,0)
 ;;=INITIAL HOSPITAL CARE^5^112
